国民彩票
Back to
Dr Melvin Chin

Dr Melvin Chin

Senior Lecturer

BSc(Med), MB BS, MHM, CHM, AFCHSM, FRACP

Medicine & Health
School of Clinical Medicine

Melvin Chin is a clinical academic medical oncologist 鈥 he cares for patients with lung, melanoma, gastrointestinal and other cancers and he teaches 国民彩票 medical students in the Oncology and Palliative Care term. He was the Head of Department-Medical Oncology at the Prince of Wales Hospital from 2015-2018 overseeing the move of clinical services into the Nelune Comprehensive Cancer Centre and collaboration with the Scientia Clinical Research. He is the chair of the South Eastern Sydney Local Health District Human Research Ethics Committee. He has contributed to numerous clinical trials and health services research studies and continues to nurture聽new research collaborations.聽
E-mail
melvin.chin@unsw.edu.au
  • Journal articles | 2025
    Chauhan A; Joseph K; Chin M; Pitcher M; Wilson C; Manias E; Ozavci G; Gan H; Newman B; Walpola RL; Seale H; Walsan R; Harrison R, 2025, 'Patient Safety Events Among People from Ethnic Minority Backgrounds: A Retrospective Medical Record Review of Australian Cancer Services', Journal of Racial and Ethnic Health Disparities,
    Journal articles | 2025
    Sugiarto MP; Jabbour V; Uebel K; Agaliotis M; Clifford B; Chin M; Harris M; Caperchione CM; Vuong K, 2025, 'Promoting physical activity among cancer survivors through general practice: a realist review', Family Practice, 42,
    Journal articles | 2024
    Gray R; Chin M; Vickers D; Indraratna P; Cranney G; Mathur G; Chen D, 2024, 'Kiosk 9Q-FA-02 Utility of CMR in Diagnosis of Metastatic Cardiac Melanoma', Journal of Cardiovascular Magnetic Resonance, 26, pp. 100930,
    Journal articles | 2024
    Gray R; Vickers D; Chin M; Mathur G; Chen DH, 2024, 'Cardiac magnetic resonance imaging in the diagnosis of cardiac tumours', European Heart Journal Cardiovascular Imaging, 25, pp. e273,
    Journal articles | 2024
    Taggart J; Chin M; Liauw W; Harris MF, 2024, 'Sharing Colorectal Cancer Follow-Up Using an E-Care Plan Between Cancer Services and Primary Health Care', Studies in Health Technology and Informatics, 310, pp. 1517 - 1518,
    Journal articles | 2023
    Chauhan A; Newman B; Roberto E; Walpola RL; Seale H; Chin M; Harrison R, 2023, 'Making it Meaningful : Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services', Patient Experience Journal, 10, pp. 34 - 48,
    Journal articles | 2023
    Newman B; Chin M; Robinson L; Chauhan A; Manias E; Wilson C; Harrison R, 2023, 'Improving Medication Safety in Cancer Services for Ethnic Minority Consumers: Protocol for a Pilot Feasibility and Acceptability Study of a Co-Designed Consumer Engagement Intervention', JMIR Research Protocols, 12, pp. e49902,
    Journal articles | 2022
    Harrison R; Chin M; Ni She E, 2022, 'What does co-design mean for Australia's diverse clinical workforce?', Australian Health Review, 46, pp. 60 - 61,
    Journal articles | 2022
    Pitiyarachchi O; Wong W; Chin M, 2022, 'Durvalumab and multimodality therapy in a patient with multiple recurrent and unresectable cutaneous squamous cell carcinoma', Internal Medicine Journal, 52, pp. 1103 - 1104,
    Journal articles | 2021
    Harrison R; Walton M; Manias E; Wilson C; Girgis A; Chin M; Leone D; Seale H; Smith AB; Chauhan A; Smith B; Walpola R, 2021, 'Codesigning consumer engagement strategies with ethnic minority consumers in Australian cancer services: The CanEngage Project protocol', BMJ Open, 11, pp. e048389,
    Journal articles | 2021
    McLean LS; Faisal W; Parakh S; Kao SC; Lewis CR; Chin MT; Voskoboynik M; Itchins MJ; Jennens RR; Broad AR; Morris TA; Solomon BJ, 2021, 'Standard-dose osimertinib in egfr-mutated non-small-cell lung adenocarcinoma with leptomeningeal disease', JCO Precision Oncology, 5, pp. 561 - 568,
    Journal articles | 2021
    Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, 31,
    Journal articles | 2020
    Ali A; Dumbrava M; Riddell K; Stewart N; Ward R; Ibrahim AK; Chin M, 2020, 'Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial', BMC Cancer, 20, pp. 342,
    Journal articles | 2020
    Vuong K; Uebel K; Agaliotis M; Jun S; Taggart J; Suchy S; Liauw W; Chin M; Webber K; Harris M, 2020, 'Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study', BMC Family Practice, 21, pp. 240,
    Journal articles | 2019
    Lamprell K; Chin M; Braithwaite J, 2019, '鈥淐an I still get a tattoo?鈥 Patients鈥 experiences across the clinical trajectory for metastatic melanoma: a dynamic narrative model of patient journey', Patient Experience Journal, 6, pp. 87 - 93,
    Journal articles | 2019
    Taggart J; Chin M; Liauw W; Dolezal A; Plahn J; Harris MF, 2019, 'Development of an interactive, web-based shared care plan to facilitate the follow-up care of colorectal cancer patients', ,
    Journal articles | 2018
    Lamprell K; Chin M; Braithwaite J, 2018, 'The plot thickens: Archetypal narrative structure in the melanoma patient journey', Critical Public Health, 5, pp. 1484053,
    Journal articles | 2018
    Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N, 2018, 'Using behaviour change and implementation science to address low referral rates in oncology', BMC Health Services Research, 18, pp. 904,
    Journal articles | 2017
    Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R, 2017, 'Advanced cancer patients鈥 attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study', European Journal of Cancer Care, 26,
    Journal articles | 2017
    Pianta TJ; Pickering JW; Succar L; Chin M; Davidson T; Buckley NA; Mohamed F; Endre ZH; Abdul Cader MF, 2017, 'Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy', Kidney and Blood Pressure Research, 42, pp. 62 - 75,
    Journal articles | 2017
    Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management,
    Journal articles | 2017
    Sch眉tze H; Chin M; Weller D; Harris MF, 2017, 'Patient, general practitioner and oncologist views regarding long-term cancer shared care.', Fam Pract, 35, pp. 323 - 329,
    Journal articles | 2016
    Au L; Grant M; Haydon A; Oliva K; Wilkins S; Segelov E; Antill Y; Peter C; Ranchod P; Polglase A; Chin M; Chip F; Skinner S; Roger W; McMurrick P; Shapiro J, 2016, '198P Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer', Annals of Oncology, 27,
    Journal articles | 2016
    Bloem LT; De Abreu Louren莽o R; Chin M; Ly B; Haas M, 2016, 'Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer', Oncology and Therapy, 4, pp. 103 - 116,
    Journal articles | 2016
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, 21, pp. 618 - 625,
    Journal articles | 2016
    He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, 21, pp. 618 - 625,
    Journal articles | 2016
    Lemech CR; Williams R; Thompson SR; McCaughan B; Chin M, 2016, 'Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: A case report', BMC Research Notes, 9, pp. 386,
    Journal articles | 2016
    Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M, 2016, 'Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: A study protocol', BMC Health Services Research, 16, pp. 89,
    Journal articles | 2015
    Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, 33, pp. 9571 - 9571,
    Journal articles | 2014
    Chin M; Ward RL, 2014, 'Targeting treatment for colorectal cancer: The EGFR antibody story', Cancer Forum, 38, pp. 39 - 43
    Journal articles | 2014
    Falchook GS; Long GV; Kurzrock R; Kim KB; Arkenau HT; Brown MP; Hamid O; Infante JR; Millward M; Pavlick A; Chin MT; O'Day SJ; Blackman SC; Martin C; Lebowitz P; Ma B; Ouellet D; Kefford RF, 2014, 'Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)', Clinical Cancer Research, 20, pp. 4449 - 4458,
    Journal articles | 2014
    Mak G; Arkenau HT; Chin M, 2014, 'Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment', Melanoma Research, 24, pp. 408 - 412,
    Journal articles | 2014
    Mak G; Chin M; Nahar N; De Souza P, 2014, 'Cutaneous metastasis of prostate carcinoma treated with radiotherapy: A case presentation', BMC Research Notes, 7, pp. 505,
    Journal articles | 2013
    Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori Journal, 99, pp. e225 - e228,
    Journal articles | 2013
    Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori, 99,
    Journal articles | 2013
    Pianta T; Chin M; Peake P; Buckley N; Pickering J; Endre Z, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', NEPHROLOGY, 18, pp. 41 - 41,
    Journal articles | 2012
    Lemech CR; Fontela A; Arkenau H-T; Chin MTM; Li S; Liauw WS; Thomas D; De Souza PL, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.', Journal of Clinical Oncology, 30, pp. e13585 - e13585,
    Journal articles | 2010
    Pearson S; Chin M; Faedo M; Ward RL, 2010, 'Rationale for treatment durations of targeted cancer agents', Lancet Oncology, 11, pp. 1113 - 1115,
    Journal articles | 2010
    Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605,
    Journal articles | 2010
    Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605,
    Journal articles | 2006
    Grimison PS; T Chin M; Harrison ML; Goldstein D; Chin M, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, 6, pp. 117,
    Journal articles | 1998
    Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS; McBride M; Chin MTM; Lee SM; Kelly B, 1998, 'Lipid lowering therapy in patients with HIV infection (multiple letters) [3]', Lancet, 352, pp. 1782 - 1783,
  • Conference Abstracts | 2024
    Chin M; Ni K; Macara M; White C; Hold G, 2024, 'Professionalizing the Scientific Review', in Professionalizing the Scientific Review, presented at 5th National HREC Conference
    Conference Abstracts | 2024
    Chong YS; Redmayne G; Chin M, 2024, 'Compassionate access drug use for oncology treatment: Single institution retrospective audit 2017鈥2024', in Asia-Pacific Journal of Clinical Oncology: Volume 20, Issue S3 COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities 13鈥15 November 2024, Gold Coast, Queensland, Vol. 20, presented at COSA, Gold Coast, Queensland, 13 November 2024 - 15 November 2024,
    Conference Abstracts | 2023
    Ma WTM; Kok PS; Kong B; Chin M, 2023, 'Real-world survival outcomes of first line pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer (NSCLC) in Australia', in Asia-Pacific Journal of Clinical Oncology: Volume 19, Issue S3 COSA's 50th Annual Scientific Meeting, 50 years of innovation in cancer care: Learning from the past to inspire the future, 1鈥3 November 2023, Wiley, Melbourne, Victoria, Vol. 19, pp. 105 - 274, presented at COSA 2023, Melbourne, Victoria, 01 November 2023 - 03 November 2023,
    Preprints | 2023
    Newman B; Chin M; Robinson L; Chauhan A; Manias E; Wilson C; Harrison R, 2023, Improving Medication Safety in Cancer Services for Ethnic Minority Consumers: Protocol for a Pilot Feasibility and Acceptability Study of a Co-Designed Consumer Engagement Intervention (Preprint),
    Conference Posters | 2023
    Taggart J; Spooner C; Simpson A; Jun S; Chin M; Liauw W; Harris MF, 2023, 'Sharing care between specialist health services and primary health care using interactive e-care plans', Online, presented at Digital Health Forum, Online, 07 February 2023
    Conference Abstracts | 2022
    Foo YM; Chin M; Lennon T, 2022, 'Prescribing rates of pneumocystis jirovecii pneumonia prophylaxis', in Asia Pacific Journal of Clinical Oncology, Wiley, Brisbane, Queensland, Australia, Vol. 18, pp. 180 - 180, presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Brisbane, Queensland, Australia, 02 November 2022 - 04 November 2022,
    Conference Posters | 2021
    Chin M, 2021, 'Telemedicine in the context of Covid-19: A qualitativestudy of cancer patients and clinicians', presented at Clinical Oncology Society Australia Annual Scientific Meeting, 16 November 2021
    Conference Posters | 2020
    Abdelmogod A; Robinson L; Coleman L; Chah K; Chin M; O'Neill S, 2020, 'Retrospective analysis of chemotherapy鈥恑nduced febrile neutropenia; Local experience towards risk鈥恇ased management', Virtual, Vol. 16, pp. 142 - 142, presented at Clinical Oncology Society Australia Annual Scientific Meeting, Virtual, 11 November 2020 - 13 November 2020,
    Conference Posters | 2020
    Bailey S; Ehrlich R; Lapin D; Chin M, 2020, 'Clinical audit of chest drain complications in medical oncology patients', Virtual, Vol. 16, pp. 142 - 143, presented at Clinical Oncology Society Australia Annual Scientific Meeting 2020, Virtual, 11 November 2020 - 13 November 2020,
    Conference Abstracts | 2019
    Chah KT; Chin M; Siu HW; Brell N, 2019, 'A retrospective audit of male prisoners referred to Cancer Services at Prince of Wales Hospital', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 134 - 134, presented at Clinical Oncology Society of Australia, Adelaide Convention Centre, 12 November 2019 - 14 November 2019,
    Conference Presentations | 2019
    Chin M; Harris M; Taggart J; Liauw W, 2019, 'Sharing the care of patients with cancer between specialists and general practitioners', presented at Australasian College of Health Service Management, Gold Coast Convention Centre, 09 October 2019 - 11 October 2019
    Conference Abstracts | 2019
    Foong M; Botes L; Shum M; Schipp D; Porwal M; Barat S; Chin M, 2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 212 - 213, presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Adelaide Convention Centre, 12 November 2019 - 14 November 2019,
    Conference Abstracts | 2019
    Foong M; Botes LP; Porwal M; Barat S; Shum M; Schipp D; Chin M, 2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 104 - 105,
    Preprints | 2019
    Taggart J; Chin M; Liauw W; Lewis J; Dolezal A; Plahn J; Harris MF, 2019, Development of an interactive, web-based shared care plan to facilitate the follow-up care of colorectal cancer patients,
    Reports | 2018
    Taggart J; Harris MF; Chin M, 2018, Cancer Shared eCare Plan Information Requirements and Care Plan Templates Jan 2018,
    Conference Abstracts | 2018
    Vaughan BK; Rossleigh M; Parasyn A; Chin M, 2018, 'The Ability of BRAF Therapy to Convert an Iodine Negative to Iodine Positive Thyroid Cancer Patient', in World Journal of Nuclear Medicine, Medknow Publications, Melbourne, Vol. 17, pp. 49 - 342, presented at 12th Congress of the World Federation of Nuclear Medicine and Biology, Melbourne, 20 April 2018 - 24 April 2018,
    Conference Papers | 2017
    Chin TTC; Botes LLB; Chin MMC, 2017, 'Compassionate Supply of Oncology Drugs Within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 188 - 188
    Conference Posters | 2017
    Williams R; Long J; Debono D; Chin MT; Taylor N, 2017, 'WORKING WITH CLINICIANS TO IDENTIFY BARRIERS TO FAMILY CANCER CLINIC REFERRALS FOR PATIENTS AT HIGH RISK OF LYNCH SYNDROME', Florence, presented at InSIGHT 7th Biennial Meeting, Florence, 05 July 2017 - 08 July 2017,
    Conference Presentations | 2016
    Harris M; Schutze H; Chin MT; Weller D; Suchy S, 2016, 'Patient, specialist and GP perspectives on sharing cancer care: It takes at least three to tango', presented at 2016 Primary Health Care Research Conference, National Convention Centre, Canberra, 08 June 2016 - 09 June 2016,
    Other | 2016
    Pal A (ed.), 2016, Between Cure and Palliation, onthewards,
    Conference Presentations | 2015
    Debono D; Taylor N; Long J; Braithwaite J; Chin MT; Williams R; Salisbury E; O'Neill S; Dunlop T; Phan-Tien K; Eykman E, 2015, 'Referral as imagined versus referral as done: mapping the referral process for genetic counselling for Lynch syndrome patients', presented at 2015 Innovations in Cancer Treatment and Care Conference, Aerial UTS Function Centre, Sydney, 15 October 2015 - 15 October 2015,
    Conference Abstracts | 2015
    Liang R; Meiser B; Smith S; Kasparian N; Lewis C; Chin M; Long G; Ward R; Menzies A; Gumniski A; Harris J; Kaur R, 2015, 'Oncology patients鈥 attitudes toward, and experiences with, somatic mutation tumour testing', Tasmania, Australia, Vol. 11, pp. 144 - 144, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Tasmania, Australia, 17 December 2015 - 19 November 2015,
    Conference Presentations | 2015
    Schutze H; Chin M; Weller D; Suchy S; Harris M, 2015, 'Attitudes to cancer follow-up care in general practice - preliminary findings', presented at Health Science Alliance - Fourth Annual Scientific Symposium, Royal Womens Hospital, Randwick, Australia, 19 November 2015 - 19 November 2015,
    Conference Papers | 2015
    Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015
    Conference Abstracts | 2015
    Taylor N; Williams R; Debono D; Chin M; Long J; Salisbury E; Butler J; Potter M; O'Neill S; Braithwaite J, (ed.), 2015, 'ACHIEVING HEALTHCARE PROFESSIONAL BEHAVIOUR CHANGE FOR DETECTION AND MANAGEMENT OF LYNCH SYNDROME', Wiley Online Library, Hobart, Tasmania, Australia, Vol. 11, pp. 102 - 103, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Hobart, Tasmania, Australia, 17 November 2015 - 19 November 2015,
    Conference Posters | 2014
    Feeney K; Chin M; Ng S; Matos M; Mak G; McKendrick J, 2014, 'AFLIBERCEPT IN METASTATIC COLORECTAL CANCER (MCRC): DATA FROM CLINICAL TRIALS, LESSONS FROM CLINICAL PRACTICE', Melbourne, Vol. 10 Supplement S8, pp. 192 - 192, presented at COSA, Melbourne, 21 October 2014 - 24 October 2014,
    Conference Presentations | 2014
    Harris M; Weller D; Ward R; Chin M; Meiser B; Crowley M, 2014, 'ATTITUDES TO CANCER FOLLOW-UP CARE IN GENERAL PRACTICE',
    Conference Presentations | 2013
    Pianta TJ; Chin M; Peake PW; Buckely NA; Pickering JW; Endre ZH, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', presented at 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology,, Brisbane, 09 September 2013 - 11 September 2013
    Conference Posters | 2013
    Pianta TJ; Peake P; Buckley NA; Pickering JW; Chin M; Endre ZH, (ed.), 2013, 'Plasma Cystatin C Should Not Be Used to Diagnose AKI after Cisplatin Therapy', Atlanta, GA, USA, Vol. 24, pp. 373A - 373A, presented at American Society of Nephrology Kidney Week 2013, Atlanta, GA, USA, 05 November 2013 - 10 November 2013
    Conference Papers | 2013
    Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116,
    Conference Papers | 2012
    Lemech C; Fontela A; Arkenau H; Chin M; Li S; Liauw WS; Thomas D; De Souza P, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours', in Journal of clinical oncology - official journal of the American Society of Clinical Oncology, American Society of Clinical Oncology, New York, pp. e13585 - e13585, presented at ASCO Annual Meeting, Chicago, USA, 01 June 2012 - 05 June 2012,
    Conference Papers | 2011
    Herder GJ; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'Describing treatment, treatment outcomes, resource use and quality of life of advanced NSCLC patients 鈥 the Lung Cancer Economics and Outcomes Research (LUCEOR) studies.', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. 1404 - 1405, presented at Proceedings of the 14th World Conference on Lung Cancer, Amsterdam,
    Conference Papers | 2009
    Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174

聽-聽Sharing follow-up care for patients with colorectal cancer

聽- Co-investigator-聽Co-designing patient engagement strategies to enhance safety in cancer services for culturally and linguistically diverse patients

- Chief Investigator H - Enhancing safety and care quality for culturally and linguistically diverse cancer consumers: A consumer engagement approach.

  • - Basic Physician Trainee Mentoring & Support Award, 2018

  • - Co-investigator

  • Investigator on the phase I BRF112680 study-聽the first-in-human trial of dabrafenib. The first patients were enrolled at the GSK Medicines Research Unit, Prince of Wales Hospital. Principal investigator of the 聽rollover study. Principal investigator of ERAS-254-01 (Naporafenib).
  • Sub-investigator in clinical trials that have included ipilimumab (CA184095), osimertinib (AURA, AURA3), brigatinib (ALTA) durvalumab (ARCTIC) and AGEN1884聽at the Prince of Wales and St George Hospitals and Scientia Clinical Research.
  • Co-investigator on the Cancer Shared Care project. The project looks at using an electronic care plan in a shared care model to support GPs and hospital cancer specialists looking after patients who have completed cancer treatment.
  • Co-investigator on the project:聽
  • Supervisor: Independent Learning Project (国民彩票 Medicine).
  • Recent completed studies include:
    • real world survival outcomes of new therapeutics in lung cancer
    • a qualitative study of cancer patients and clinicians on using telemedicine in the context of Covid-19
    • an audit of prisoners with cancer in NSW
    • a comparison of聽data quality between聽cancer clinical and research databases
    • the use of compassionate access drugs to treat cancer聽
    • the use of Theoretical Domains Framework聽Implementation to at risk of Lynch Syndrome
    • mapping to a literary model of fictional heroic journeys
    • using qualitative data examined from to inform the design of聽a sustainable model of GP follow up for patients completing cancer treatments